仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Zolbetuximab （IMAB362） is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors